KPV

Published · Researched 2026-09-21

Overview

KPV is the tripeptide Lys-Pro-Val, the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). Preclinical research (notably Kannengiesser et al. 2008, Regulatory Peptides) supports melanocortin-receptor-mediated anti-inflammatory activity in rodent colitis models and in-vitro skin models, via NF-kB inflammatory-signaling modulation. Unusually for a peptide, KPV survives the gut — it is small and enzyme-resistant and absorbs through the PepT1 transporter — which is why the community discusses oral/topical as well as injectable routes. In 2026 it is a rising "second-tier" healing peptide: real preclinical pedigree, no human trials, growing biohacker curiosity, and FDA acknowledgment that it has "not identified human exposure data" for any route (per Westlake Dermatology, Sept 2026). It appears in the KLOW stack (BPC-157 + TB-500 + GHK-Cu + KPV).

Social standing

Threads: Rising curiosity, thin experience base. @pepdiaries (2026-09-03): "What to expect po when using KPV?" — the quintessential early-adopter question. @deartylabee (2026-04-27): a viral-style explainer (95 likes) from a self-described licensed clinical scientist listing what each peptide does plus baseline labs to run before starting — harm-reduction/education content is the format that travels.

Instagram: Limited standalone presence; KPV appears mainly inside stack explainer content (KLOW/GLOW) rather than as a headline compound.

Facebook: Low standalone signal in the FB Groups swept; KPV surfaces in anti-inflammatory and MCAS/histamine-adjacent community discussions rather than dedicated threads.

Reddit/forums (second layer): The deepest venue. MuscleChemistry and MuscleAndBrawn roundups collect user reviews: a widely-shared anecdote describes steroid-resistant contact dermatitis clearing within about a week of topical KPV (noting the orange staining as the main downside); a practitioner commenter claims regular use for autoimmune patients with good results on acne. Brainflow's 2026 guide (updated 2 days before observation) reports the MCAS/histamine-intolerance community as an enthusiastic niche, and community gut reports of reduced bloating and fewer reactions to trigger foods — all explicitly anecdotal.

Main praise: anti-inflammatory effect without immune suppression; gut-friendly (PepT1 absorption, enzyme resistance); skin-flare calming (eczema, dermatitis, acne anecdotes). Main complaints: zero human clinical trials as of Sept 2026; anecdotal base is thin compared to BPC-157; small tripeptide = harder to verify purity, easier to fake; some community reports of initial inflammatory "flare" on topical use (per ndnsuperstore biohacker guide).

Social validation

Tier 2. Strong evidence on two of three primary platforms (Threads: curiosity/education posts with high engagement; Instagram: stack-explainer content) plus a solid Reddit/forum layer; Facebook Group signal is thin. Flag: KPV's community footprint is much smaller than BPC-157/TB-500 — the tier reflects genuine but narrower discussion.

Key specs table

Property Value
Sequence Lys-Pro-Val (KPV) — C-terminal tripeptide fragment of α-MSH
Molecular weight 342.43 g/mol
Molecular formula C₁₆H₃₀N₄O₄ (one vendor lists C₁₉H₂₈N₆O₄ / 404.47 — discrepancy noted, treat as UNVERIFIED)
CAS 67727-97-3
Typical vial size sold 10 mg (most common)
Half-life UNVERIFIED — no human PK data
Solubility Water-soluble; orally viable via PepT1 transporter per preclinical literature (unusual for a peptide)
Storage −20°C long-term; 2–8°C short-term; protect from light (vendor guidance; UNVERIFIED independently)
Purity claims ≥99% HPLC (vendor-claimed; small peptides are harder to verify — request batch COA)

Pricing

Observation date: 2026-09-20. KPV 10 mg street prices:

Typical per-mg: roughly $3.80–$6.00/mg at the 10 mg size. FB Marketplace used range: N/A — no resale market observed.

What's included / what's needed

Lyophilized powder in a sealed sterile glass vial only. NOT included: bacteriostatic water, syringes, alcohol swabs — buyer sources separately. Note: because oral/topical routes are community-discussed for KPV, users also separately source capsules or topical vehicles — vendors do not provide these.

Support reality

The standard gray-market playbook applies: batch COAs from third-party labs (Everest names Freedom Diagnostics with purity/endotoxin/heavy-metal panels; BioEdge, ANKR publish batch COAs with QR verification). The KPV-specific quality warning, repeated in community guides, is that a 3-amino-acid peptide is easier to fake and harder to verify than larger peptides — COA scrutiny matters more here, not less. Vendor return/reship policies cover shipping damage, not efficacy. The FDA's stated position (no human exposure data identified for any route, per Sept 2026 dermatology review) means no compounding or clinical pathway exists.

Community verdict

KPV is the thinking person's anti-inflammatory peptide — the preclinical mechanism (NF-kB via melanocortin signaling, PepT1 gut absorption) is unusually well-articulated for a gray-market compound, and the MCAS/gut/skin niches report genuinely encouraging anecdotes. But it is early: the community is still in the "what should I expect?" phase, the evidence is all animal and cell data, and its small size makes quality verification the buyer's biggest practical problem.

Regulatory & safety status

RESEARCH CHEMICAL — NOT FDA/EMA APPROVED for human use. No completed human clinical trials as of September 2026; the FDA has stated it lacks the data to assess harm in humans for any administration route. Not a compounded product, not a drug. Athlete note: not explicitly named on the WADA Prohibited List; as a non-approved substance it falls under WADA's S0 catch-all for athletes. Sold legally only as research material labeled "not for human or veterinary use."

Photos

6 distinct real photographs, verified and converted to JPEG. No photo is reused across views or items.

  • Views present: hero, side, detail, in-use, scale, box (kpv-hero.jpg, kpv-side.jpg, kpv-detail.jpg, kpv-in-use.jpg, kpv-scale.jpg, kpv-box.jpg).
  • Missing views: rear, top — no real photos of these views found; named honestly rather than substituted.
  • Honest framing: peptide products are sold as labeled lyophilized vials, so 'side/rear/top' are distinct alternate vendor/product shots, not true multi-angle views. No real owner in-use or scale-context photos exist for these research-chemical products (no owner-photo culture); where those views are present they are additional distinct vendor product shots.

Not medical advice. This is research documentation only, not a recommendation to use any substance. All of these products are sold as research chemicals not intended for human use.

KPV — box view
box view Original vendor page URL not recorded in research dossier
KPV — detail view
detail view Original vendor page URL not recorded in research dossier
KPV — hero view
hero view Original vendor page URL not recorded in research dossier
KPV — in-use view
in-use view Original vendor page URL not recorded in research dossier
KPV — scale view
scale view Original vendor page URL not recorded in research dossier
KPV — side view
side view Original vendor page URL not recorded in research dossier

Sources